The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort

被引:39
作者
Gade, I. L. [1 ]
Braekkan, S. K. [2 ,3 ]
Naess, I. A. [4 ]
Hansen, J. -B. [2 ,3 ]
Cannegieter, S. C. [5 ]
Overvad, K. [6 ,7 ]
Jensvoll, H. [2 ,3 ]
Hammerstrom, J. [8 ]
Blix, K. [2 ,3 ]
Tjonneland, A. [9 ]
Kristensen, S. R. [10 ]
Severinsen, M. T. [1 ,11 ]
机构
[1] Aalborg Univ, Dept Clin Med, Sdr Skovvej 15, DK-9000 Aalborg, Denmark
[2] UiT Arctic Univ Norway, K G Jebsen Thrombosis Res & Expertise Ctr TREC, Dept Clin Med, Tromso, Norway
[3] Univ Hosp North Norway, Div Internal Med, Tromso, Norway
[4] Trondheim Reg & Univ Hosp, Dept Hematol, Trondheim, Norway
[5] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands
[6] Aarhus Univ, Sect Epidemiol, Dept Publ Hlth, Aarhus, Denmark
[7] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark
[8] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Trondheim, Norway
[9] Danish Canc Soc Res Ctr, Diet Genes & Environm, Copenhagen, Denmark
[10] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark
[11] Aalborg Univ Hosp, Dept Hematol, Aalborg, Denmark
关键词
cancer; epidemiology; incidence; metastasis; venous thromboembolism; RISK-FACTOR; EPIDEMIOLOGY; POPULATION; SURVIVAL; COMPARABILITY; MORTALITY; REGISTRY; QUALITY; PROFILE; HEALTH;
D O I
10.1111/jth.13752
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Absolute measures of the impact of cancer stage on the incidence of venous thromboembolism (VTE) in patients with distinct cancer types have not been investigated in a large population-based cohort study. Objectives: To investigate differences in the incidence rates of objectively confirmed VTE according to the development of cancer in a large population-based cohort study. Cancer type and stage at the time of diagnosis were taken into account. Patients and Methods: The Scandinavian Thrombosis and Cancer Cohort includes data regarding cancer types, stages and objectively confirmed VTE diagnoses among 144 952 participants followed from 1993 to 2012. We studied stage-specific incidence rates of VTE, and calculated incidence rate differences (IRDs) for VTE according to stages in patients with 10 types of solid cancer. Results: During the entire follow-up, 335 VTEs occurred, of which 293 occurred within 5 years. The IRD of VTE in patients with distant metastasis as compared with those with localized disease indicated large variation depending on cancer type. The highest IRD was observed for pancreatic cancer (IRD of 187.0 9 10(-3) person-years [p-y]; 95% confidence interval [CI] - 6.7 to 380.8), and the lowest IRD was observed for prostate cancer (IRD of 3.7 x 10(-3) p-y; 95% CI - 7 to 15.2). Regional spread as compared with localized disease also indicated large variation depending on cancer type; the highest IRD was observed for uterine cancer (IRD of 37.6 x 10(-3) p-y; 95% CI - 23.7 to 99), and the IRDs for breast and prostate cancer were close to zero. Conclusion: More advanced cancer at the time of diagnosis was associated with a higher risk of VTE, but the strength of the associations differed substantially between cancer types.
引用
收藏
页码:1567 / 1575
页数:9
相关论文
共 46 条
[1]   Venous thromboembolism in patients with colorectal cancer: Incidence and effect on survival [J].
Alcalay, A ;
Wun, T ;
Khatri, V ;
Chew, HK ;
Harvey, D ;
Zhou, H ;
White, RH .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1112-1118
[2]   Interpretability and importance of functionals in competing risks and multistate models [J].
Andersen, Per Kragh ;
Keiding, Niels .
STATISTICS IN MEDICINE, 2012, 31 (11-12) :1074-1088
[3]  
[Anonymous], 2009, MOD CANC MET KVAL, P1
[4]   Introduction to the Analysis of Survival Data in the Presence of Competing Risks [J].
Austin, Peter C. ;
Lee, Douglas S. ;
Fine, Jason P. .
CIRCULATION, 2016, 133 (06) :601-609
[5]   Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality [J].
Ay, C. ;
Posch, F. ;
Kaider, A. ;
Zielinski, C. ;
Pabinger, I. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (03) :390-397
[6]   High risk of venous thrombosis in patients with pancreatic cancer: A cohort study of 202 patients [J].
Blom, JW ;
Osanto, S ;
Rosendaal, FR .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (03) :410-414
[7]   Malignancies, prothrombotic mutations, and the risk of venous thrombosis [J].
Blom, JW ;
Doggen, CJM ;
Osanto, S ;
Rosendaal, FR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (06) :715-722
[8]   Mean platelet volume is a risk factor for venous thromboembolism: the Troms⊘ study [J].
Braekkan, S. K. ;
Mathiesen, E. B. ;
Njolstad, I. ;
Wilsgaard, T. ;
Stormer, J. ;
Hansen, J. B. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (01) :157-162
[9]   The incidence of venous thromboembolism among patients with primary lung cancer [J].
Chew, H. K. ;
Davies, A. M. ;
Wun, T. ;
Harvey, D. ;
Zhou, H. ;
White, R. H. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (04) :601-608
[10]   Incidence of venous thromboembolism and the impact on survival in breast cancer patients [J].
Chew, Helen K. ;
Wun, Theodore ;
Harvey, Danielle J. ;
Zhou, Hong ;
White, Richard H. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) :70-76